{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:21:23Z","timestamp":1787318483080,"version":"build-2736575974"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13023-017-0598-0","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T06:25:57Z","timestamp":1489645557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature"],"prefix":"10.1186","volume":"12","author":[{"given":"Benedikt","family":"Schoser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarekegn","family":"Geberhiwot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derralynn","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Kissel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam C.","family":"Madathil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Orlikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael I.","family":"Polkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harm A. W. M.","family":"Tiddens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,16]]},"reference":[{"key":"598_CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/mus.10487","volume":"29","author":"C Perrin","year":"2004","unstructured":"Perrin C, Unterborn JN, Ambrosio CD, Hill NS. Pulmonary complications of chronic neuromuscular diseases and their management. Muscle Nerve. 2004;29:5\u201327.","journal-title":"Muscle Nerve"},{"key":"598_CR2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0272-5231(21)00957-6","volume":"15","author":"SK Epstein","year":"1994","unstructured":"Epstein SK. An overview of respiratory muscle function. Clin Chest Med. 1994;15:619\u201339.","journal-title":"Clin Chest Med"},{"key":"598_CR3","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.nmd.2015.01.011","volume":"25","author":"VA Sansone","year":"2015","unstructured":"Sansone VA, Gagnon C. 207th ENMC Workshop on chronic respiratory insufficiency in myotonic dystrophies: management and implications for research, 27\u201329 June 2014, Naarden, The Netherlands. Neuromuscul Disord. 2015;25:432\u201342.","journal-title":"Neuromuscul Disord"},{"key":"598_CR4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5603\/ARM.27836","volume":"77","author":"N Ambrosino","year":"2009","unstructured":"Ambrosino N, Gherardi M, Carpen\u00e8 N. End stage chronic obstructive pulmonary disease. Pneumonol Alergol Pol. 2009;77:173\u20139.","journal-title":"Pneumonol Alergol Pol"},{"key":"598_CR5","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.arbres.2012.12.003","volume":"49","author":"E Farrero","year":"2013","unstructured":"Farrero E, Ant\u00f3n A, Egea CJ, et al. Guidelines for the management of respiratory complications in patients with neuromuscular disease. Arch Bronconeumol. 2013;49:306\u201313.","journal-title":"Arch Bronconeumol"},{"key":"598_CR6","first-page":"CD002277","volume":"12","author":"P Gajdos","year":"2012","unstructured":"Gajdos P, Chevret S, Toyka KV. Intravenous immunoglobulin for myasthenia gravis. Cochrane Database Syst Rev. 2012;12:CD002277.","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl","key":"598_CR7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0022-510X(96)00089-5","volume":"139","author":"M Carvalho de","year":"1996","unstructured":"de Carvalho M, Matias T, Coelho F, Evangelista T, Pinto A, Luis ML. Motor neuron disease presenting with respiratory failure. J Neurol Sci. 1996;139(Suppl):117\u201322.","journal-title":"J Neurol Sci"},{"key":"598_CR8","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1164\/rccm.201210-1804CI","volume":"187","author":"JO Benditt","year":"2013","unstructured":"Benditt JO, Boitano LJ. Pulmonary issues in patients with chronic neuromuscular disease. Am J Respir Crit Care Med. 2013;187:1046\u201355.","journal-title":"Am J Respir Crit Care Med"},{"key":"598_CR9","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.parkreldis.2010.07.004","volume":"16","author":"R Mehanna","year":"2010","unstructured":"Mehanna R, Jankovic J. Respiratory problems in neurologic movement disorders. Parkinsonism Relat Disord. 2010;16:628\u201338.","journal-title":"Parkinsonism Relat Disord"},{"key":"598_CR10","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/archneur.1988.00520350083020","volume":"45","author":"SC Smeltzer","year":"1988","unstructured":"Smeltzer SC, Utell MJ, Rudick RA, Herndon RM. Pulmonary function and dysfunction in multiple sclerosis. Arch Neurol. 1988;45:1245\u20139.","journal-title":"Arch Neurol"},{"key":"598_CR11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1183\/09031936.00182208","volume":"34","author":"N Ambrosino","year":"2009","unstructured":"Ambrosino N, Carpene N, Gherardi M. Chronic respiratory care for neuromuscular diseases in adults. Eur Respir J. 2009;34:444\u201351.","journal-title":"Eur Respir J"},{"key":"598_CR12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/ene.12582","volume":"22","author":"M Boentert","year":"2015","unstructured":"Boentert M, Karabul N, Wenninger S, et al. Sleep-related symptoms and sleep-disordered breathing in adult Pompe disease. Eur J Neurol. 2015;22:369\u201376.","journal-title":"Eur J Neurol"},{"key":"598_CR13","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00415-005-0922-9","volume":"252","author":"LP Winkel","year":"2005","unstructured":"Winkel LP, Hagemans ML, van Doorn PA, et al. The natural course of non-classic Pompe\u2019s disease; a review of 225 published cases. J Neurol. 2005;252:875\u201384.","journal-title":"J Neurol"},{"key":"598_CR14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1172-6-34","volume":"6","author":"D G\u03cbng\u00f6r","year":"2011","unstructured":"G\u03cbng\u00f6r D, de Vries JM, Hop WC, et al. Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy. Orphanet J Rare Dis. 2011;6:34.","journal-title":"Orphanet J Rare Dis"},{"key":"598_CR15","first-page":"1016","volume":"51","author":"S Mehta","year":"2006","unstructured":"Mehta S. Neuromuscular disease causing acute respiratory failure. Respir Care. 2006;51:1016\u201321. discussion 21\u20133.","journal-title":"Respir Care"},{"key":"598_CR16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/00003246-200301000-00044","volume":"31","author":"T Sharshar","year":"2003","unstructured":"Sharshar T, Chevret S, Bourdain F, Raphael JC. Early predictors of mechanical ventilation in Guillain-Barre syndrome. Crit Care Med. 2003;31:278\u201383.","journal-title":"Crit Care Med"},{"key":"598_CR17","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S1474-4422(06)70603-2","volume":"5","author":"MC Durand","year":"2006","unstructured":"Durand MC, Porcher R, Orlikowski D, et al. Clinical and electrophysiological predictors of respiratory failure in Guillain-Barre syndrome: a prospective study. Lancet Neurol. 2006;5:1021\u20138.","journal-title":"Lancet Neurol"},{"key":"598_CR18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1474-4422(05)70326-4","volume":"5","author":"SC Bourke","year":"2006","unstructured":"Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol. 2006;5:140\u20137.","journal-title":"Lancet Neurol"},{"key":"598_CR19","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1212\/WNL.0b013e3181bc01a4","volume":"73","author":"RG Miller","year":"2009","unstructured":"Miller RG, Jackson CE, Kasarskis EJ, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive\/behavioral impairment (an evidence-based review): report of the quality standards subcommittee of the American academy of neurology. Neurology. 2009;73:1227\u201333.","journal-title":"Neurology"},{"key":"598_CR20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1378\/chest.122.1.92","volume":"122","author":"JR Bach","year":"2002","unstructured":"Bach JR. Amyotrophic lateral sclerosis: prolongation of life by noninvasive respiratory AIDS. Chest. 2002;122:92\u20138.","journal-title":"Chest"},{"key":"598_CR21","first-page":"829","volume":"51","author":"JO Benditt","year":"2006","unstructured":"Benditt JO. The neuromuscular respiratory system: physiology, pathophysiology, and a respiratory care approach to patients. Respir Care. 2006;51:829\u201337. discussion 37\u20139.","journal-title":"Respir Care"},{"key":"598_CR22","first-page":"1348","volume":"54","author":"JA Evans","year":"2009","unstructured":"Evans JA, Whitelaw WA. The assessment of maximal respiratory mouth pressures in adults. Respir Care. 2009;54:1348\u201359.","journal-title":"Respir Care"},{"key":"598_CR23","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1164\/rccm.166.4.518","volume":"166","author":"American Thoracic Society\/European Respiratory Society (ATS\/ERS)","year":"2002","unstructured":"American Thoracic Society\/European Respiratory Society (ATS\/ERS). ATS\/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166:518\u2013624.","journal-title":"Am J Respir Crit Care Med"},{"key":"598_CR24","first-page":"84","volume":"80","author":"H Ranu","year":"2011","unstructured":"Ranu H, Wilde M, Madden B. Pulmonary function tests. Ulster Med J. 2011;80:84\u201390.","journal-title":"Ulster Med J"},{"key":"598_CR25","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1590\/S1807-59322011000700007","volume":"66","author":"LT Gomieiro","year":"2011","unstructured":"Gomieiro LT, Nascimento A, Tanno LK, Agondi R, Kalil J, Giavina-Bianchi P. Respiratory exercise program for elderly individuals with asthma. Clinics (Sao Paulo). 2011;66:1163\u20139.","journal-title":"Clinics (Sao Paulo)"},{"key":"598_CR26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3945\/ajcn.112.034207","volume":"96","author":"C Gontijo-Amaral","year":"2012","unstructured":"Gontijo-Amaral C, Guimaraes EV, Camargos P. Oral magnesium supplementation in children with cystic fibrosis improves clinical and functional variables: a double-blind, randomized, placebo-controlled crossover trial. Am J Clin Nutr. 2012;96:50\u20136.","journal-title":"Am J Clin Nutr"},{"key":"598_CR27","doi-asserted-by":"crossref","unstructured":"Rodrigues A, Da Silva ML, Berton DC, et al. Maximal Inspiratory Pressure: Does the Choice of Reference Values Actually Matter? Chest 2016. doi:10.1016\/j.chest.2016.11.045.","DOI":"10.1016\/j.chest.2016.11.045"},{"key":"598_CR28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/17482960601030188","volume":"8","author":"M Mendoza","year":"2007","unstructured":"Mendoza M, Gelinas DF, Moore DH, Miller RG. A comparison of maximal inspiratory pressure and forced vital capacity as potential criteria for initiating non-invasive ventilation in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8:106\u201311.","journal-title":"Amyotroph Lateral Scler"},{"key":"598_CR29","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/thx.2006.072884","volume":"62","author":"J Steier","year":"2007","unstructured":"Steier J, Kaul S, Seymour J, et al. The value of multiple tests of respiratory muscle strength. Thorax. 2007;62:975\u201380.","journal-title":"Thorax"},{"key":"598_CR30","first-page":"27","volume":"8","author":"M Golparvar","year":"2005","unstructured":"Golparvar M, Ahmadi F, Saghaei M. Effects of progesterone on the ventilatory performance in adult trauma patients during partial support mechanical ventilation. Arch Iran Med. 2005;8:27\u201331.","journal-title":"Arch Iran Med"},{"key":"598_CR31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00005373-199104000-00002","volume":"31","author":"RC Mackersie","year":"1991","unstructured":"Mackersie RC, Karagianes TG, Hoyt DB, Davis JW. Prospective evaluation of epidural and intravenous administration of fentanyl for pain control and restoration of ventilatory function following multiple rib fractures. J Trauma. 1991;31:443\u20139.","journal-title":"J Trauma"},{"key":"598_CR32","first-page":"329","volume":"66","author":"M Sosis","year":"1987","unstructured":"Sosis M, Larijani GE, Marr AT. Priming with atracurium. Anesth Analg. 1987;66:329\u201332.","journal-title":"Anesth Analg"},{"key":"598_CR33","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1001\/archinte.1995.00430050072008","volume":"155","author":"MS Skorodin","year":"1995","unstructured":"Skorodin MS, Tenholder MF, Yetter B, et al. Magnesium sulfate in exacerbations of chronic obstructive pulmonary disease. Arch Intern Med. 1995;155:496\u2013500.","journal-title":"Arch Intern Med"},{"key":"598_CR34","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1378\/chest.121.4.1070","volume":"121","author":"J Weisberg","year":"2002","unstructured":"Weisberg J, Wanger J, Olson J, et al. Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients. Chest. 2002;121:1070\u20138.","journal-title":"Chest"},{"key":"598_CR35","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1183\/09031936.06.00098105","volume":"27","author":"S Andreas","year":"2006","unstructured":"Andreas S, Herrmann-Lingen C, Raupach T, et al. Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial. Eur Respir J. 2006;27:972\u20139.","journal-title":"Eur Respir J"},{"key":"598_CR36","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/ppul.22688","volume":"48","author":"GM Buyse","year":"2013","unstructured":"Buyse GM, Goemans N, van den Hauwe M, Meier T. Effects of glucocorticoids and idebenone on respiratory function in patients with duchenne muscular dystrophy. Pediatr Pulmonol. 2013;48:912\u201320.","journal-title":"Pediatr Pulmonol"},{"key":"598_CR37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/mus.20450","volume":"33","author":"EP Schmidt","year":"2006","unstructured":"Schmidt EP, Drachman DB, Wiener CM, Clawson L, Kimball R, Lechtzin N. Pulmonary predictors of survival in amyotrophic lateral sclerosis: use in clinical trial design. Muscle Nerve. 2006;33:127\u201332.","journal-title":"Muscle Nerve"},{"key":"598_CR38","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3109\/17482960902991773","volume":"11","author":"F Baumann","year":"2010","unstructured":"Baumann F, Henderson RD, Morrison SC, et al. Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11:194\u2013202.","journal-title":"Amyotroph Lateral Scler"},{"key":"598_CR39","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0025-6196(12)62080-1","volume":"66","author":"PC Gay","year":"1991","unstructured":"Gay PC, Westbrook PR, Daube JR, Litchy WJ, Windebank AJ, Iverson R. Effects of alterations in pulmonary function and sleep variables on survival in patients with amyotrophic lateral sclerosis. Mayo Clin Proc. 1991;66:686\u201394.","journal-title":"Mayo Clin Proc"},{"key":"598_CR40","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1183\/09031936.02.00082702","volume":"19","author":"MB Chaudri","year":"2002","unstructured":"Chaudri MB, Liu C, Hubbard R, Jefferson D, Kinnear WJ. Relationship between supramaximal flow during cough and mortality in motor neurone disease. Eur Respir J. 2002;19:434\u20138.","journal-title":"Eur Respir J"},{"key":"598_CR41","first-page":"186","volume":"13","author":"JP Lopes Almeida","year":"2012","unstructured":"Lopes Almeida JP, Braga AC, Pinto A, et al. Respiratory predictors of ALS survival in home ventilated-compliant patients. Amyotroph Lateral Scler. 2012;13:186\u20137.","journal-title":"Amyotroph Lateral Scler"},{"key":"598_CR42","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jpainsymman.2012.10.283","volume":"46","author":"R Benzo","year":"2013","unstructured":"Benzo R, Siemion W, Novotny P, et al. Factors to inform clinicians about the end of life in severe chronic obstructive pulmonary disease. J Pain Symptom Manage. 2013;46:491\u20139.","journal-title":"J Pain Symptom Manage"},{"key":"598_CR43","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1164\/ajrccm.153.3.8630580","volume":"153","author":"K Gray-Donald","year":"1996","unstructured":"Gray-Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;153:961\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"598_CR44","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1164\/ajrccm.157.6.9705017","volume":"157","author":"AM Schols","year":"1998","unstructured":"Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:1791\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"598_CR45","first-page":"36","volume":"48","author":"VA Hodgev","year":"2006","unstructured":"Hodgev VA, Kostianev SS. Maximal inspiratory pressure predicts mortality in patients with chronic obstructive pulmonary disease in a five-year follow-up. Folia Med (Plovdiv). 2006;48:36\u201341.","journal-title":"Folia Med (Plovdiv)"},{"key":"598_CR46","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.rmed.2007.06.021","volume":"101","author":"S Budweiser","year":"2007","unstructured":"Budweiser S, Jorres RA, Criee CP, et al. Prognostic value of mouth occlusion pressure in patients with chronic ventilatory failure. Respir Med. 2007;101:2343\u201351.","journal-title":"Respir Med"},{"key":"598_CR47","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1161\/01.CIR.103.17.2153","volume":"103","author":"FJ Meyer","year":"2001","unstructured":"Meyer FJ, Borst MM, Zugck C, et al. Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance. Circulation. 2001;103:2153\u20138.","journal-title":"Circulation"},{"key":"598_CR48","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/HJR.0b013e3283030a7e","volume":"16","author":"L Frankenstein","year":"2009","unstructured":"Frankenstein L, Nelles M, Meyer FJ, et al. Validity, prognostic value and optimal cutoff of respiratory muscle strength in patients with chronic heart failure changes with beta-blocker treatment. Eur J Cardiovasc Prev Rehabil. 2009;16:424\u20139.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"598_CR49","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1164\/ajrccm.158.4.9710079","volume":"158","author":"AA Ionescu","year":"1998","unstructured":"Ionescu AA, Chatham K, Davies CA, Nixon LS, Enright S, Shale DJ. Inspiratory muscle function and body composition in cystic fibrosis. Am J Respir Crit Care Med. 1998;158:1271\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"598_CR50","first-page":"S245","volume":"60","author":"CA Marroni","year":"2014","unstructured":"Marroni CA, Galant LH. Functional capacity, respiratory muscle strength, and oxygen consumption predict mortality in patients with cirrhosis. J Hepatol. 2014;60:S245 [Abstract].","journal-title":"J Hepatol"},{"key":"598_CR51","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1136\/thx.2004.021915","volume":"59","author":"J Palen van der","year":"2004","unstructured":"van der Palen J, Rea TD, Manolio TA, et al. Respiratory muscle strength and the risk of incident cardiovascular events. Thorax. 2004;59:1063\u20137.","journal-title":"Thorax"},{"key":"598_CR52","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1164\/rccm.201604-0848OC","volume":"195","author":"MI Polkey","year":"2017","unstructured":"Polkey MI, Lyall RA, Yang K, Johnson E, Leigh PN, Moxham J. Respiratory muscle strength as a predictive biomarker for survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med. 2017;195:86\u201395.","journal-title":"Am J Respir Crit Care Med"},{"key":"598_CR53","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1164\/ajrccm.160.1.9805055","volume":"160","author":"MF Phillips","year":"1999","unstructured":"Phillips MF, Smith PE, Carroll N, Edwards RH, Calverley PM. Nocturnal oxygenation and prognosis in Duchenne muscular dystrophy. Am J Respir Crit Care Med. 1999;160:198\u2013202.","journal-title":"Am J Respir Crit Care Med"},{"key":"598_CR54","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/HJR.0b013e3282f0d6ea","volume":"15","author":"L Frankenstein","year":"2008","unstructured":"Frankenstein L, Meyer FJ, Sigg C, et al. Is serial determination of inspiratory muscle strength a useful prognostic marker in chronic heart failure? Eur J Cardiovasc Prev Rehabil. 2008;15:156\u201361.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"598_CR55","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s13539-013-0109-7","volume":"4","author":"D Habedank","year":"2013","unstructured":"Habedank D, Meyer FJ, Hetzer R, Anker SD, Ewert R. Relation of respiratory muscle strength, cachexia and survival in severe chronic heart failure. J Cachexia Sarcopenia Muscle. 2013;4:277\u201385.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"598_CR56","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1002\/cncr.28624","volume":"120","author":"D Hui","year":"2014","unstructured":"Hui D, Bansal S, Morgado M, Dev R, Chisholm G, Bruera E. Phase angle for prognostication of survival in patients with advanced cancer: preliminary findings. Cancer. 2014;120:2207\u201314.","journal-title":"Cancer"},{"key":"598_CR57","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1136\/thx.49.9.915","volume":"49","author":"M Jackson","year":"1994","unstructured":"Jackson M, Smith I, King M, Shneerson J. Long term non-invasive domiciliary assisted ventilation for respiratory failure following thoracoplasty. Thorax. 1994;49:915\u20139.","journal-title":"Thorax"},{"key":"598_CR58","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1378\/chest.127.6.1904","volume":"127","author":"TA Nizet","year":"2005","unstructured":"Nizet TA, van den Elshout FJ, Heijdra YF, van de Ven MJ, Mulder PG, Folgering HT. Survival of chronic hypercapnic COPD patients is predicted by smoking habits, comorbidity, and hypoxemia. Chest. 2005;127:1904\u201310.","journal-title":"Chest"},{"key":"598_CR59","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1378\/chest.128.1.145","volume":"128","author":"AC White","year":"2005","unstructured":"White AC, Terrin N, Miller KB, Ryan HF. Impaired respiratory and skeletal muscle strength in patients prior to hematopoietic stem-cell transplantation. Chest. 2005;128:145\u201352.","journal-title":"Chest"},{"key":"598_CR60","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1164\/ajrccm.154.5.8912741","volume":"154","author":"MI Polkey","year":"1996","unstructured":"Polkey MI, Kyroussis D, Hamnegard CH, Mills GH, Green M, Moxham J. Diaphragm strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;154:1310\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"598_CR61","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.rmed.2005.06.008","volume":"100","author":"S Euteneuer","year":"2006","unstructured":"Euteneuer S, Windisch W, Suchi S, Kohler D, Jones PW, Schonhofer B. Health-related quality of life in patients with chronic respiratory failure after long-term mechanical ventilation. Respir Med. 2006;100:477\u201386.","journal-title":"Respir Med"},{"key":"598_CR62","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1183\/09031936.02.00211902","volume":"19","author":"C Dellborg","year":"2002","unstructured":"Dellborg C, Olofson J, Midgren B, Caro O, Skoogh BE, Sullivan M. Quality of life in patients with chronic alveolar hypoventilation. Eur Respir J. 2002;19:113\u201320.","journal-title":"Eur Respir J"},{"key":"598_CR63","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.pmrj.2009.03.003","volume":"1","author":"DA Trojan","year":"2009","unstructured":"Trojan DA, Arnold DL, Shapiro S, et al. Fatigue in post-poliomyelitis syndrome: association with disease-related, behavioral, and psychosocial factors. PM R. 2009;1:442\u20139.","journal-title":"PM R"},{"key":"598_CR64","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0007-0971(85)90047-6","volume":"79","author":"SM Allen","year":"1985","unstructured":"Allen SM, Hunt B, Green M. Fall in vital capacity with posture. Br J Dis Chest. 1985;79:267\u201371.","journal-title":"Br J Dis Chest"},{"key":"598_CR65","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/thx.38.8.616","volume":"38","author":"NM Braun","year":"1983","unstructured":"Braun NM, Arora NS, Rochester DF. Respiratory muscle and pulmonary function in polymyositis and other proximal myopathies. Thorax. 1983;38:616\u201323.","journal-title":"Thorax"},{"key":"598_CR66","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1183\/09031936.00.00286702","volume":"20","author":"N Hart","year":"2002","unstructured":"Hart N, Cramer D, Ward SP, et al. Effect of pattern and severity of respiratory muscle weakness on carbon monoxide gas transfer and lung volumes. Eur Respir J. 2002;20:996\u20131002.","journal-title":"Eur Respir J"},{"key":"598_CR67","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2002-33028","volume":"23","author":"VA DePalo","year":"2002","unstructured":"DePalo VA, McCool FD. Respiratory muscle evaluation of the patient with neuromuscular disease. Semin Respir Crit Care Med. 2002;23:201\u20139.","journal-title":"Semin Respir Crit Care Med"},{"key":"598_CR68","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0022-510X(01)00617-7","volume":"191","author":"CE Jackson","year":"2001","unstructured":"Jackson CE, Rosenfeld J, Moore DH, et al. A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS\/MND patients. J Neurol Sci. 2001;191:75\u20138.","journal-title":"J Neurol Sci"},{"key":"598_CR69","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.spinee.2009.08.451","volume":"9","author":"D Inal-Ince","year":"2009","unstructured":"Inal-Ince D, Savci S, Arikan H, et al. Effects of scoliosis on respiratory muscle strength in patients with neuromuscular disorders. Spine J. 2009;9:981\u20136.","journal-title":"Spine J"},{"key":"598_CR70","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12028-011-9575-y","volume":"17","author":"H Prigent","year":"2012","unstructured":"Prigent H, Orlikowski D, Letilly N, et al. Vital capacity versus maximal inspiratory pressure in patients with Guillain-Barre syndrome and myasthenia gravis. Neurocrit Care. 2012;17:236\u20139.","journal-title":"Neurocrit Care"},{"key":"598_CR71","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archneurol.2009.1","volume":"66","author":"PH Gordon","year":"2009","unstructured":"Gordon PH, Corcia P, Lacomblez L, et al. Defining survival as an outcome measure in amyotrophic lateral sclerosis. Arch Neurol. 2009;66:758\u201361.","journal-title":"Arch Neurol"},{"key":"598_CR72","first-page":"A219","volume":"74","author":"R Abresch","year":"2010","unstructured":"Abresch R, McDonald C, Han J, et al. Pulmonary function characteristics of boys with duchenne and Becker muscular dystrophy by age groups and steroid use: One-year data from the CINRG longitudinal study project. Neurology. 2010;74:A219.","journal-title":"Neurology"},{"key":"598_CR73","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","volume":"362","author":"AT Ploeg van der","year":"2010","unstructured":"van der Ploeg AT, Clemens PR, Corzo D, et al. A randomized study of alglucosidase alfa in late-onset Pompe\u2019s disease. N Engl J Med. 2010;362:1396\u2013406.","journal-title":"N Engl J Med"},{"key":"598_CR74","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymgme.2012.09.015","volume":"107","author":"AT Ploeg van der","year":"2012","unstructured":"van der Ploeg AT, Barohn R, Carlson L, et al. Open-label extension study following the late-onset treatment study (LOTS) of alglucosidase Alfa. Mol Genet Metab. 2012;107:456\u201361.","journal-title":"Mol Genet Metab"},{"key":"598_CR75","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/17482960903082218","volume":"10","author":"BC Cheah","year":"2009","unstructured":"Cheah BC, Boland RA, Brodaty NE, et al. INSPIRATIonAL\u2014INSPIRAtory muscle training in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:384\u201392.","journal-title":"Amyotroph Lateral Scler"},{"key":"598_CR76","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ymgme.2011.06.012","volume":"104","author":"NA Beek van der","year":"2011","unstructured":"van der Beek NA, van Capelle CI, van der Velden-van Etten KI, et al. Rate of progression and predictive factors for pulmonary outcome in children and adults with Pompe disease. Mol Genet Metab. 2011;104:129\u201336.","journal-title":"Mol Genet Metab"},{"key":"598_CR77","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1136\/thx.35.8.603","volume":"35","author":"A Troyer De","year":"1980","unstructured":"De Troyer A, Borenstein S, Cordier R. Analysis of lung volume restriction in patients with respiratory muscle weakness. Thorax. 1980;35:603\u201310.","journal-title":"Thorax"},{"key":"598_CR78","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0929-6646(09)60185-6","volume":"105","author":"LL Chiang","year":"2006","unstructured":"Chiang LL, Yu CT, Liu CY, Lo YL, Kuo HP, Lin HC. Six-month nocturnal nasal positive pressure ventilation improves respiratory muscle capacity and exercise endurance in patients with chronic hypercapnic respiratory failure. J Formos Med Assoc. 2006;105:459\u201367.","journal-title":"J Formos Med Assoc"},{"key":"598_CR79","first-page":"24","volume":"58","author":"T Shioya","year":"2008","unstructured":"Shioya T, Satake M, Sato K, et al. Long-term effect of the beta2-receptor agonist procaterol on daily life performance and exercise capacity in patients with stable chronic obstructive pulmonary disease. Clinical study with special reference to health-related quality of life and activities of daily living. Arzneimittelforschung. 2008;58:24\u20138.","journal-title":"Arzneimittelforschung"},{"key":"598_CR80","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.HCR.0000314208.40170.00","volume":"28","author":"K O\u2019Brien","year":"2008","unstructured":"O\u2019Brien K, Geddes EL, Reid WD, Brooks D, Crowe J. Inspiratory muscle training compared with other rehabilitation interventions in chronic obstructive pulmonary disease: a systematic review update. J Cardiopulm Rehabil Prev. 2008;28:128\u201341.","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"598_CR81","first-page":"885","volume":"55","author":"A Borghi-Silva","year":"2010","unstructured":"Borghi-Silva A, Mendes RG, Toledo AC, et al. Adjuncts to physical training of patients with severe COPD: oxygen or noninvasive ventilation? Respir Care. 2010;55:885\u201394.","journal-title":"Respir Care"},{"key":"598_CR82","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jamda.2009.12.083","volume":"11","author":"CR Wetering van","year":"2010","unstructured":"van Wetering CR, Hoogendoorn M, Broekhuizen R, et al. Efficacy and costs of nutritional rehabilitation in muscle-wasted patients with chronic obstructive pulmonary disease in a community-based setting: a prespecified subgroup analysis of the INTERCOM trial. J Am Med Dir Assoc. 2010;11:179\u201387.","journal-title":"J Am Med Dir Assoc"},{"key":"598_CR83","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/HCR.0b013e31822f0f61","volume":"31","author":"BM Deering","year":"2011","unstructured":"Deering BM, Fullen B, Egan C, et al. Acupuncture as an adjunct to pulmonary rehabilitation. J Cardiopulm Rehabil Prev. 2011;31:392\u20139.","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"598_CR84","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/resp.12122","volume":"18","author":"E Pleguezuelos","year":"2013","unstructured":"Pleguezuelos E, Perez ME, Guirao L, et al. Effects of whole body vibration training in patients with severe chronic obstructive pulmonary disease. Respirology. 2013;18:1028\u201334.","journal-title":"Respirology"},{"key":"598_CR85","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3138\/ptc.2009-62","volume":"63","author":"JL Wetzel","year":"2011","unstructured":"Wetzel JL, Fry DK, Pfalzer LA. Six-minute walk test for persons with mild or moderate disability from multiple sclerosis: performance and explanatory factors. Physiother Can. 2011;63:166\u201380.","journal-title":"Physiother Can"},{"key":"598_CR86","doi-asserted-by":"crossref","first-page":"776","DOI":"10.4187\/respcare.00783","volume":"56","author":"Z Dimitriadis","year":"2011","unstructured":"Dimitriadis Z, Kapreli E, Konstantinidou I, Oldham J, Strimpakos N. Test\/retest reliability of maximum mouth pressure measurements with the MicroRPM in healthy volunteers. Respir Care. 2011;56:776\u201382.","journal-title":"Respir Care"},{"key":"598_CR87","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1183\/09031936.94.07020398","volume":"7","author":"CH Hamnegard","year":"1994","unstructured":"Hamnegard CH, Wragg S, Kyroussis D, Aquilina R, Moxham J, Green M. Portable measurement of maximum mouth pressures. Eur Respir J. 1994;7:398\u2013401.","journal-title":"Eur Respir J"},{"key":"598_CR88","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm\/139.1.277","volume":"139","author":"G McElvaney","year":"1989","unstructured":"McElvaney G, Blackie S, Morrison NJ, Wilcox PG, Fairbarn MS, Pardy RL. Maximal static respiratory pressures in the normal elderly. Am Rev Respir Dis. 1989;139:277\u201381.","journal-title":"Am Rev Respir Dis"},{"key":"598_CR89","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1136\/jnnp.74.12.1685","volume":"74","author":"N Hart","year":"2003","unstructured":"Hart N, Polkey MI, Sharshar T, et al. Limitations of sniff nasal pressure in patients with severe neuromuscular weakness. J Neurol Neurosurg Psychiatry. 2003;74:1685\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"598_CR90","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1164\/rccm.200403-314OC","volume":"171","author":"RK Morgan","year":"2005","unstructured":"Morgan RK, McNally S, Alexander M, Conroy R, Hardiman O, Costello RW. Use of sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med. 2005;171:269\u201374.","journal-title":"Am J Respir Crit Care Med"},{"key":"598_CR91","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ppul.22847","volume":"49","author":"S Khirani","year":"2014","unstructured":"Khirani S, Ramirez A, Aubertin G, et al. Respiratory muscle decline in Duchenne muscular dystrophy. Pediatr Pulmonol. 2014;49:473\u201381.","journal-title":"Pediatr Pulmonol"},{"key":"598_CR92","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/1531-8249(199912)46:6<887::AID-ANA11>3.0.CO;2-L","volume":"46","author":"JW Fitting","year":"1999","unstructured":"Fitting JW, Paillex R, Hirt L, Aebischer P, Schluep M. Sniff nasal pressure: a sensitive respiratory test to assess progression of amyotrophic lateral sclerosis. Ann Neurol. 1999;46:887\u201393.","journal-title":"Ann Neurol"},{"key":"598_CR93","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1164\/ajrccm.162.4.9910034","volume":"162","author":"D Stefanutti","year":"2000","unstructured":"Stefanutti D, Benoist MR, Scheinmann P, Chaussain M, Fitting JW. Usefulness of sniff nasal pressure in patients with neuromuscular or skeletal disorders. Am J Respir Crit Care Med. 2000;162:1507\u201311.","journal-title":"Am J Respir Crit Care Med"},{"key":"598_CR94","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1183\/09031936.00094707","volume":"31","author":"N Terzi","year":"2008","unstructured":"Terzi N, Orlikowski D, Fermanian C, et al. Measuring inspiratory muscle strength in neuromuscular disease: one test or two? Eur Respir J. 2008;31:93\u20138.","journal-title":"Eur Respir J"},{"key":"598_CR95","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mus.23282","volume":"46","author":"KL Gruis","year":"2012","unstructured":"Gruis KL, Lechtzin N. Respiratory therapies for amyotrophic lateral sclerosis: a primer. Muscle Nerve. 2012;46:313\u201331.","journal-title":"Muscle Nerve"},{"key":"598_CR96","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/pgmj.74.870.208","volume":"74","author":"N Syabbalo","year":"1998","unstructured":"Syabbalo N. Assessment of respiratory muscle function and strength. Postgrad Med J. 1998;74:208\u201315.","journal-title":"Postgrad Med J"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-017-0598-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T10:08:28Z","timestamp":1658830108000},"score":1,"resource":{"primary":{"URL":"http:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-017-0598-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,16]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["598"],"URL":"https:\/\/doi.org\/10.1186\/s13023-017-0598-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,16]]},"article-number":"52"}}